10x Genomics, Inc. — The Genetic comeback story no one’s talking10x Genomics, Inc.BATS:TXGwithout_worriesThe name alone implies exponential potential, 10x Genomics. Ironically, that’s exactly what the chart hints at, (resistances shown as horizontal black lines). After a brutal multi-year decline from its euphoric highs, TXG may now be on the cusp of a significant structural reversal. The story At the height of market exuberance, TXG topped around $212, a textbook display of speculative mania. What followed was a 90% collapse, erasing most of the pandemic-era valuation premium. The 10 day chart above highlights the evolution of this decline within a well defined descending channel, marked by systematic lower highs and lower lows. Every bounce met resistance within the channel. until now. For the first time since 2021, price action has broken above the descending resistance line with conviction, supported by a confirmed bullish divergence on the RSI The technicals 1. Support confirmed: The lower channel trend line and RSI trend both acted as long-term resistance. The most recent test (mid-2025) coincided with a failed breakdown and swift recovery, a classic bear trap formation. 2. RSI breakout: RSI has now broken the three year downtrend resistance for the first time since 2021. When this occurred previously (look left), TXG went on to rally more than 300%. 3. Measured moves: The immediate forecast sits around $33–40, representing a +125% move from current levels. The secondary resistance near $56–60 offers a +280% gain potential should momentum persist. 4. Volume confirmation: Increasing volume in recent weeks suggests accumulation, not retail speculation, but institutional re-entry. Conclusions After a three year bear market, TXG is showing early structural signs of recovery. The technical alignment, the RSI breakout, price reclaiming multi year support, and expanding volume suggests a regime change may be underway. Is this the beginning of a new biotech bull phase? Maybe. But unlike the AI frenzy or the crypto euphoria, this one won’t announce itself on social media. It’ll just quietly 5x while everyone’s still arguing about interest rates. Patience. Accumulation. Confirmation. Then conviction. Ww Disclaimer ======================================================= This is not financial advice. Nor should it be mistaken for prophecy. If you invest based on the opinions of strangers on the internet, then what you’re trading isn’t a stock, it’s your own discernment. I hold no position in TXG at the time of writing. I merely observe the chart, and it suggests, rather persuasively, that the patient may be showing vital signs. Whether it walks again depends, as always, on evidence.. . not faith.